Features Partner Sites Information LinkXpress
Sign In
Demo Company

Compact Ultralow Temperature Storage Solutions Available

By BiotechDaily International staff writers
Posted on 01 Jun 2014
Print article
Image: The Hamilton BIOS M Ultra-low Temperature Storage System (Photo courtesy of Hamilton Storage Technologies).
Image: The Hamilton BIOS M Ultra-low Temperature Storage System (Photo courtesy of Hamilton Storage Technologies).
A line of advanced deep freezers with robotic sample access is now available for biotech and life science laboratories.

The Hamilton Storage Technologies (Franklin, MA, USA) BiOS M and L are two compact high-density systems for the ultralow-temperature storage of sensitive biological samples.

All samples within the BiOS systems are stored in -80 degrees Celsius chest freezer compartments to maintain temperature stability. All internal workflows, including sample picking, are optimized to keep samples at ultralow temperatures at all times. System parts are easily accessible for service and maintenance, while one-dimensional and two-dimensional barcode reading and sample tracking provide complete chain-of-custody documentation—a requirement for forensic laboratories. Multiple backup systems ensure that samples stay at -80 degrees Celsius in the event of power failure.

“By adding smaller configurations of our high-capacity BiOS -80 degree Celsius storage system, more labs have access to state-of-the-art sample storage within steps of their sample preparation and analysis stations,” said Dr. Martin Frey, PhD, head of Hamilton Storage Technologies. “This reduces the likelihood that results may be compromised.”

Related Links:
Hamilton Storage Technologies

Print article



view channel
Image: Left: Green actin fibers create architecture of the cell. Right: With cytochalasin D added, actin fibers disband and reform in the nuclei (Photo courtesy of the University of North Carolina).

Actin in the Nucleus Triggers a Process That Directs Stem Cells to Mature into Bone

A team of cell biologists has discovered why treatment of mesenchymal stem cells (MSCs) with the mycotoxin cytochalasin D directs them to mature into bone cells (osteoblasts) rather than into fat cells... Read more


view channel

Molecular Light Shed on “Dark” Cellular Receptors

Scientists have created a new research tool to help find homes for orphan cell-surface receptors, toward better understanding of cell signaling, developing new therapeutics, and determining causes of drug side-effects. The approach may be broadly useful for discovering interactions of orphan receptors with endogenous, naturally... Read more


view channel

Purchase of Biopharmaceutical Company Will Boost Development of Nitroxyl-Based Cardiovascular Disease Drugs

A major international biopharmaceutical company has announced the acquisition of a private biotech company that specializes in the development of drugs for treatment of cardiovascular disease. Bristol-Myers Squibb Co. (New York, NY, USA) has initiated the process to buy Cardioxyl Pharmaceuticals Inc. (Chapel Hill, NC, USA).... Read more
Copyright © 2000-2015 Globetech Media. All rights reserved.